Atul Dandekar, CSBO at Maze Therapeutics, Inc. (MAZE), sold 15,000 shares at $45.13 ($681K) on 2026-02-27, disclosed to the SEC on 2026-03-03.
Open-market sale of $681k MAZE by CSBO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.13 | 3,739 | $169K | 24.8% |
| 2 | $45.13 | 3,739 | $169K | 24.8% |
| 3 | $45.72 | 3,761 | $172K | 25.2% |
| 4 | $45.72 | 3,761 | $172K | 25.2% |
| Total | $45.43 avg | 15,000 | $681K | 100% |
| Filing → |
| MAZE | SELL | 2026-08-31 | $207K | — | Filing → |
| MAZE | SELL | 2026-07-31 | $205K | — | Filing → |
| MAZE | SELL | 2026-07-01 | $210K | — | Filing → |